公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2018 | Combined delivery of sorafenib and a MEK inhibitor using CXCR4-targeted nanoparticles reduces hepatic fibrosis and prevents tumor development | Yun-Chieh Sung; Ya-Chi Liu; Po-Han Chao; Chih-Chun Chang; Pei-Ru Jin; Ts-Ting Lin; Ja-An Lin; HUI-TENG CHENG ; Jane Wang; Charles P. Lai; Ling-Hsuan Chen; Anthony Y. Wu; Ting-Lun Ho; Tsaiyu Chiang; Dong-Yu Gao; Dan G. Duda; Yunching Chen | Theranostics | 68 | 60 | |
2018 | Docetaxel-carboxymethylcellulose nanoparticles ameliorate CCl 4 -induced hepatic fibrosis in mice | Chih-Chun Chang; Yang Yang; Dong-Yu Gao; HUI-TENG CHENG ; Bryan Hoang; Po-Han Chao; Ling-Hsuan Chen; Joseph Bteich; Tsaiyu Chiang; Jia-Yu Liu; Shyh-Dar Li; Yunching Chen | Journal of Drug Targeting | 10 | 8 |